Keyphrases
Adult Patients
9%
Antileukemic Activity
9%
Cancer-specific
9%
Cellular Metabolism
9%
Clinical Trials
9%
CRIPSR-Cas9
9%
Derived Carbon
9%
Epigenetic Therapy
9%
Epigenetics
9%
Experiment in Vivo
9%
Experimental Therapeutics
9%
Genetic Loss
9%
Glutaminase 1 (GLS1)
100%
Glutaminase Inhibitor
9%
Glutamine
27%
Glutaminolysis
100%
Hematological Malignancies
18%
Human Cancer
18%
In Cancer
9%
Metabolic
18%
Metabolic Rewiring
9%
Notch1
27%
Oncogene
9%
Pathway Genes
9%
Pediatric
9%
Pharmacological Inhibitors
9%
Refractory Disease
9%
Selective Inhibitor
9%
Selective Targeting
9%
Solid Tumors
9%
Stemness
18%
Synthetic Lethal
9%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
100%
Therapeutic Approaches
9%
Therapeutic Effect
9%
Therapeutic Target
100%
Tricarboxylic Acid Cycle (TCA cycle)
9%
Biochemistry, Genetics and Molecular Biology
Cas9
8%
Cell Metabolism
8%
Clinical Trial
8%
Epigenetics
16%
Genetics
8%
Glutaminase
100%
Glutamine
25%
Glutaminolysis
100%
Oncogene
8%